|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online August 3, 2005
doi: 10.1242/10.1242/jcs.02469
Research Article |
1 Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University, 79106 Freiburg, Germany
2 Department of Biomedical Sciences, University of Bradford, Bradford, BD7 1DP, UK
3 German Cancer Research Center (Deutsches Krebsforschungszentrum), 69120 Heidelberg, Germany
* Author for correspondence (e-mail: thomas.reinheckel{at}uniklinik-freiburg.de)
Accepted 5 May 2005
Mice deficient for cathepsin L (CTSL) show epidermal hyperplasia due to a hyperproliferation of basal keratinocytes. Here we show that the critical function of CTSL in the skin is keratinocyte specific. This is revealed by transgenic re-expression of CTSL in the keratinocytes of ctsl-/- mice, resulting in a rescue of the ctsl-/- skin phenotype. Cultivation of primary mouse keratinocytes with fibroblast- and keratinocyte-conditioned media, as well as heterologous organotypic co-cultures of mouse fibroblasts and human keratinocytes, showed that the altered keratinocyte proliferation is caused primarily by CTSL-deficiency in keratinocytes. In the absence of EGF, wild type and CTSL-knockout keratinocytes proliferate with the same rates, while in presence of EGF, ctsl-/- keratinocytes showed enhanced proliferation compared with controls. Internalization and degradation of radioactively labeled EGF was identical in both ctsl-/- and ctsl+/+ keratinocytes. However, ctsl-/- keratinocytes recycled more EGF to the cell surface, where it is bound to the EGF-receptor, which is also more abundant in ctsl-/- cells. We conclude that the hyperproliferation of keratinocytes in CTSL-knockout mice is caused by an enhanced recycling of growth factors and growth factor receptors from the endosomes to the keratinocyte plasma membrane, which result in sustained growth stimulation.
Key words: Cathepsins, Epidermis, Hair follicle, Lysosomes, Mice, Knockout
This article has been cited by other articles:
![]() |
V. Patel, B. L. Hood, A. A. Molinolo, N. H. Lee, T. P. Conrads, J. C. Braisted, D. B. Krizman, T. D. Veenstra, and J. S. Gutkind Proteomic Analysis of Laser-Captured Paraffin-Embedded Tissues: A Molecular Portrait of Head and Neck Cancer Progression Clin. Cancer Res., February 15, 2008; 14(4): 1002 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Spira, J. Stypmann, D. J. Tobin, I. Petermann, C. Mayer, S. Hagemann, O. Vasiljeva, T. Gunther, R. Schule, C. Peters, et al. Cell Type-specific Functions of the Lysosomal Protease Cathepsin L in the Heart J. Biol. Chem., December 21, 2007; 282(51): 37045 - 37052. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kotsyfakis, A. Sa-Nunes, I. M. B. Francischetti, T. N. Mather, J. F. Andersen, and J. M. C. Ribeiro Antiinflammatory and Immunosuppressive Activity of Sialostatin L, a Salivary Cystatin from the Tick Ixodes scapularis J. Biol. Chem., September 8, 2006; 281(36): 26298 - 26307. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Cheng, K. Hitomi, I. M. J. J. van Vlijmen-Willems, G. J. de Jongh, K. Yamamoto, K. Nishi, C. Watts, T. Reinheckel, J. Schalkwijk, and P. L. J. M. Zeeuwen Cystatin M/E Is a High Affinity Inhibitor of Cathepsin V and Cathepsin L by a Reactive Site That Is Distinct from the Legumain-binding Site: A NOVEL CLUE FOR THE ROLE OF CYSTATIN M/E IN EPIDERMAL CORNIFICATION J. Biol. Chem., June 9, 2006; 281(23): 15893 - 15899. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Petermann, C. Mayer, J. Stypmann, M. L. Biniossek, D. J. Tobin, M. A. Engelen, T. Dandekar, T. Grune, L. Schild, C. Peters, et al. Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice FASEB J, June 1, 2006; 20(8): 1266 - 1268. [Abstract] [Full Text] [PDF] |
||||